Skip to main content

Synergus

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
    • IGES group
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Hands-on market access support
      • Reimbursement dossier / HTA dossier
      • Reimbursement/DRG analysis
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

You are here

Home ยป Blog
  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Reimbursement/DRG analysis
      • Reimbursement dossier / HTA dossier
      • Hands-on market access support
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog
Nordic HTA activity
19 Apr 2016

In the below graphs, you can see the HTA activity in the Nordic countries. Particullary interesting to see the increased used of mini-HTA assessments in Norway and Sweden. 

  • HTA Update Search
  • Tags: 

    • HTA
    • Denmark
    • Finland
    • Norway
    • Sweden
    • LinkedIn
    • Twitter

    Contact us

    Tags

    Breast cancer
    Corona virus
    DHS France
    EMA
    EQ-5D
    EU HTAR
    EU HTAR IVD
    EU HTAR Medtech
    Germany
    HQ_RWD
    Imaging
    Myeloma
    Obesity
    Patient Registries
    Pharma
    RWD Scientific Impact
    RWD_DK
    Transferability of Outcomes
    Coverage with Evidence Development
    DHS Germany
    Italy
    Melanoma
    Multiple Sclerosis
    Quality of Life
    R-RCT
    Registries
    SF-36
    DHS Belgium
    Funding
    HQRWE_Fracture
    Netherlands
    Rheumatoid Arthritis
    Throat Cancer
    Co-payment
    Empowered Patients
    Lung Cancer
    Norway
    Stroke
    Digital Heath Strategies
    France
    Innovation Funding
    Mental Health
    Data Science in Oncology
    Finland
    Heart Failure
    Out-patient procedures
    Artificial Intelligence
    Denmark
    Diabetes
    Dementia
    Sweden
    Alzheimer
    The Netherlands
    Oncology
    United Kingdom
    Country specific
    China
    COVID-19
    Value Based Healthcare
    HTA
    RefugeeMD
    Medical Device
    Disease Specific
    Health Economics
    Legislation
    Market Access
    IVD
    Digital Health
    Real World Data
    Real World Evidence
    • Home
    • About
    • RWE impact
    • Market Access
    • HEOR
    • Events/Webinars
    • News
    • Blog